Se ha denunciado esta presentación.
Utilizamos tu perfil de LinkedIn y tus datos de actividad para personalizar los anuncios y mostrarte publicidad más relevante. Puedes cambiar tus preferencias de publicidad en cualquier momento.
Transfer Membrane Market | Increasing R&D Spending By Pharmaceutical and
Biotechnology Companies
According to the new mark...
presence of leading transfer membrane manufacturers in the region, availability of government and
private financial suppor...
Próximo SlideShare
Cargando en…5
×

de

Transfer Membrane Market | Increasing R&D Spending By Pharmaceutical and Biotechnology Companies Slide 1 Transfer Membrane Market | Increasing R&D Spending By Pharmaceutical and Biotechnology Companies Slide 2
Próximo SlideShare
What to Upload to SlideShare
Siguiente
Descargar para leer sin conexión y ver en pantalla completa.

0 recomendaciones

Compartir

Descargar para leer sin conexión

Transfer Membrane Market | Increasing R&D Spending By Pharmaceutical and Biotechnology Companies

Descargar para leer sin conexión

The transfer membrane market is projected to reach USD 187.9 million by 2023 from USD 174.8 million in 2018, at a CAGR of 1.5% during the forecast period.

For more details : https://www.marketsandmarkets.com/Market-Reports/transfer-membrane-market-36975865.html

Audiolibros relacionados

Gratis con una prueba de 30 días de Scribd

Ver todo
  • Sé el primero en recomendar esto

Transfer Membrane Market | Increasing R&D Spending By Pharmaceutical and Biotechnology Companies

  1. 1. Transfer Membrane Market | Increasing R&D Spending By Pharmaceutical and Biotechnology Companies According to the new market research report " Transfer Membrane Market by Type (PVDF, Nitrocellulose, Nylon), Transfer Method (Tank, Semi-dry, Dry), Application (Western, Northern, Southern Blot, Protein Sequencing), End user (Academia, Diagnolab, Pharmaceutical Companies) - Global Forecast to 2023" the transfer membrane market is projected to reach USD 187.9 million by 2023 from USD 174.8 million in 2018, at a CAGR of 1.5% during the forecast period. Factors such as increasing public and private funding for life science research, the significantly high prevalence of target diseases across the globe, and increasing R&D spending by pharmaceutical and biotechnology companies are expected to drive the growth of market. Browse 64 market data Tables and 35 Figures spread through 124 Pages Download Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=36975865 The report analyzes the global market by type, transfer method, application, end user, and region. On the basis of type, the market is divided into nylon membranes, nitrocellulose membranes, and PVDF membranes. In 2018, PVDF Membranes are expected to command for the major share of the market. This can be attributed to the advantages of PVDF membranes over its counterparts, such as better protein retention, strength, chemical compatibility, and wide applications in western blotting. Based on end user, the market is segmented into academic and research institutes, pharmaceutical and biotechnology companies, diagnostic laboratories, and other end users. Among these, the academic and research institutes segment is expected to account for the largest share of the transfer membrane market in 2018, owing it to the rising financial support from private as well as government bodies for life science research in various nations. Regional Growth, Development and Demand Analysis: North America is expected to account for the largest share of the global transfer membrane market in 2018, followed by Europe. The large share in the North American region is mainly attributed to the
  2. 2. presence of leading transfer membrane manufacturers in the region, availability of government and private financial support for life science research, and high target disease prevalence in the region. Some of The Major Players In Transfer Membrane Market : Merck KGaA (US), Thermo Fisher Scientific (US), Bio-Rad Laboratories (US), GE Healthcare (US), PerkinElmer (US), Pall Coporation (US), Advansta (US), GVS (Italy), Santa Cruz Biotechnology (US), Abcam (UK), ATTO Corporation (Japan), Carl Roth (Germany), Macherey- Nagel (Germany), Azure Biosystems (US), and Axiva Sichem Biotech (India) Get Sample Copy of This Report @https://www.marketsandmarkets.com/requestsampleNew.asp?id=36975865

The transfer membrane market is projected to reach USD 187.9 million by 2023 from USD 174.8 million in 2018, at a CAGR of 1.5% during the forecast period. For more details : https://www.marketsandmarkets.com/Market-Reports/transfer-membrane-market-36975865.html

Vistas

Total de vistas

8

En Slideshare

0

De embebidos

0

Número de embebidos

0

Acciones

Descargas

0

Compartidos

0

Comentarios

0

Me gusta

0

×